Smruthi Organics (540686) Stock Overview
Manufactures and markets active pharmaceutical ingredient (API) products to India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
540686 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Smruthi Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹121.60 |
| 52 Week High | ₹169.00 |
| 52 Week Low | ₹103.00 |
| Beta | 0.18 |
| 1 Month Change | -5.19% |
| 3 Month Change | 4.42% |
| 1 Year Change | -24.87% |
| 3 Year Change | -22.28% |
| 5 Year Change | 180.83% |
| Change since IPO | 109.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540686 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -6.7% | -0.4% | -0.08% |
| 1Y | -24.9% | 8.4% | -1.7% |
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned 8.4% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned -1.7% over the past year.
Price Volatility
| 540686 volatility | |
|---|---|
| 540686 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: 540686 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540686's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 267 | Purushotham Eaga | smruthiorganics.com |
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine.
Smruthi Organics Limited Fundamentals Summary
| 540686 fundamental statistics | |
|---|---|
| Market cap | ₹1.39b |
| Earnings (TTM) | ₹35.63m |
| Revenue (TTM) | ₹1.26b |
Is 540686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540686 income statement (TTM) | |
|---|---|
| Revenue | ₹1.26b |
| Cost of Revenue | ₹665.70m |
| Gross Profit | ₹594.38m |
| Other Expenses | ₹558.75m |
| Earnings | ₹35.63m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.11 |
| Gross Margin | 47.17% |
| Net Profit Margin | 2.83% |
| Debt/Equity Ratio | 23.5% |
How did 540686 perform over the long term?
See historical performance and comparisonDividends
Does 540686 pay a reliable dividends?
See 540686 dividend history and benchmarks| Smruthi Organics dividend dates | |
|---|---|
| Ex Dividend Date | Jun 13 2025 |
| Dividend Pay Date | Jul 20 2025 |
| Days until Ex dividend | 29 days |
| Days until Dividend pay date | 8 days |
Does 540686 pay a reliable dividends?
See 540686 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/11 03:48 |
| End of Day Share Price | 2025/07/11 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Smruthi Organics Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |